Bulnexo 8 mg/2 mg sublingvalne tablete
| Name | Bulnexo 8 mg/2 mg sublingvalne tablete |
|---|---|
| Marketing Authorisation Number | HR-H-065726451 |
| Active Substance | buprenorfinklorid naloksonklorid dihidrat |
| Composition | jedna sublingvalna tableta sadrži 8 mg buprenorfina (u obliku buprenorfinklorida) i 2 mg naloksona (u obliku naloksonklorid dihidrata) |
| Pharmaceutical Form | sublingvalna tableta |
| Manufacturer | Ethypharm, Le Grand Quevilly, Francuska
Ethypharm, Chateauneuf-en-Thymerais, Francuska |
| Marketing Authorisation Holder | Alkaloid - INT d.o.o., Šlandrova ulica 4, Ljubljana - Črnuče, Slovenija |
| Marketing Authorisation Date | 14.06.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/228 |
| Registration Number | 381-12-01/38-22-02 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | poseban recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N07BC51 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
